Stocks to watch after Google DeepMind’s announcement

Posted: 1 December 2020 6:00 pm

Google DeepMind’s AI is revolutionizing healthcare — a trend you can invest in.

DeepMind — an AI research firm and subsidiary of Google — has made a groundbreaking healthcare discovery. And the breakthrough illustrates a massive emerging healthcare trend that news-savvy investors can capitalize on.

DeepMind’s protein folding breakthrough

On Monday, DeepMind announced that its AlphaFold system had finally solved a protein folding challenge — one that had baffled and eluded the scientific community for decades. The successful passing of this protein folding test means that AlphaFold is officially capable of deciphering the structure of proteins from an amino acid sequence in just a few days time: a resource-intensive task that used to take years.

This is a scientific breakthrough with incredible potential — especially for the healthcare industry.

How will DeepMind’s discovery change healthcare?

The success of DeepMind’s AlphaFold system could change the way we treat disease, from blocking the progress of infection to preventing neurodegenerative disorders. Potential applications for the technology are abundant, but many experts suggest such rapid protein folding may dramatically impact the way we develop future vaccines.

In fact, back in March, AlphaFold released a prediction about the structures of proteins associated with SARS-CoV-2: the virus responsible for COVID-19. And its subsequent cracking of the protein folding problem demonstrates a sizable step forward in the healthcare industry. The faster we can identify a protein’s 3D shape, the quicker we can develop effective medical treatments.

DeepMind’s breakthrough showcases how powerful and prevalent AI technology will become in the healthcare industry. And this emerging trend presents an opportunity for investors seeking growth stocks.

Competitors in AI healthcare

Of course, DeepMind isn’t the only company aiming to revolutionize healthcare with the help of AI technology. In fact, there are several key players making impressive strides in this space.

Diagnostics Robotics is responsible for an AI triage tool used by healthcare facilities across the US, Israel and India. And from March to April, this tool helped triage over 2.5 million patients. The company’s CEO says that demand for its AI triage tool skyrocketed over the course of the year, and that industry demand is 7.5 times what it was before the pandemic.

Benevolent AI is another example of an AI company making a difference in healthcare. During the pandemic, it made use of an internal knowledge graph that uses AI technology to identify existing medicines that could be used to treat COVID-19. The drug it suggested — baricitinib — was granted emergency approval from the US Food and Drug Association (FDA) nine months later.

As pandemic-fueled AI breakthroughs continue to surface, investors have the opportunity to back a trend with exponential potential.

AI healthcare stocks

Outside an investment in Google (GOOGL), keep your eye on the following stocks in the AI healthcare space through your trading platform of choice:

  • ABB (ABB)
  • Globus Medical (GMED)
  • Healthcare Catalyst (HCAT)
  • Intuitive Surgical (ISRG)
  • Nuance Communications (NUAN)
  • Teladoc Health (TDOC)

Photo: Google

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site